MPM BioVentures 2018 GP LLC, 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 64,820 shares at $33.84 ($1.5M) on 2021-04-07, disclosed to the SEC on 2021-04-09.
Scheduled sale ($1.5M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 15,670 | $0 | 0.0% |
| 2 | $32.07 | 3,164 | $101K | 6.7% |
| 3 | $32.07 | 3,164 | $101K | 6.7% |
| 4 | $32.84 | 1,842 | $60K | 4.0% |
| 5 | $32.84 | 1,842 | $60K | 4.0% |
| 6 | $33.84 | 777 |
| $26K |
| 1.7% |
| 7 | $30.51 | 19,057 | $581K | 38.2% |
| 8 | $30.51 | 19,057 | $581K | 38.2% |
| 9 | $31.01 | 247 | $8K | 0.5% |
| Total | $23.46 avg | 64,820 | $1.5M | 100% |
| Filing → |
| ITOS | SELL | 2022-01-06 | $12.5M | — | Filing → |
| ITOS | SELL | 2021-10-18 | $939K | — | Filing → |
| ITOS | SELL | 2021-10-14 | $2.3M | — | Filing → |